Dr. Reddy's signs multi-country deal for gastroenterology in India & select Emerging Markets

Pharma |  News | 0 Comment | 19 May, 2022

Indian firm Dr. Reddy’s Laboratories has entered into an exclusive partnership with South Korea-based HK inno.N Co...Read more

Kyowa Kirin to build new biopharma API building

Pharma |  News | 0 Comment | 20 May, 2022

Japanese firm Kyowa Kirin has decided to build a new active pharmaceutical ingredient (API) manufacturing building (HB7 ...Read more

Vetter Achieves a Three-Peat in Winning the Best Managed Companies Award

Pharma |  News | 0 Comment | 18 May, 2022

Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family (second from left) along with ...Read more

UK-based Croda announces new pharma business

Pharma |  News | 0 Comment | 18 May, 2022

UK-based Croda has announced that its Health Care division will now become Croda Pharma, bringing its core speciality ex...Read more

US FDA approves Lilly's COVID-19 drug

Pharma |  News | 0 Comment | 16 May, 2022

Eli Lilly and Company and Incyte have announced that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT&n...Read more

Novo Holdings, Shionogi offer treatment for invasive fungal infections in Europe and Asia

Pharma |  News | 0 Comment | 16 May, 2022

Novo Holdings has announced that its portfolio company F2G has entered into a strategic collaboration with Japan-based S...Read more

WODA combining forces to reach patients with rare diseases across globe

Pharma |  News | 0 Comment | 13 May, 2022

EffRx Pharmaceuticals, Medis, Orpharm, OrphanDC, and Vector Pharma, announced the newly formed World Orphan Drug Allianc...Read more

Taiwan strengthens treatment offering for inflammation and pain after cataract surgery

Pharma |  News | 0 Comment | 13 May, 2022

Taiwan-based Formosa Pharmaceuticals and AimMax Therapeutics have reported successful top-line results from CPN-301, the...Read more

Aravax appoints Dr Brett Haumann to Board of Directors

Pharma |  News | 0 Comment | 11 May, 2022

Australia's Aravax, a clinical stage biotechnology company focused on developing the most advanced novel therapy for pea...Read more

Immuron appoints Steven Lydeamore as Chief Executive Officer

Pharma |  News | 0 Comment | 06 May, 2022

Immuron Limited, an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeuti...Read more

Orion partners with Jemincare for novel non-opioid drug candidate for pain treatment

Pharma |  News | 0 Comment | 06 May, 2022

Finland's Orion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclu...Read more

5 Transformative Merits of Blockchain in Pharma

Pharma |  Analysis | By Ayesha Siddiqui | 0 Comment | 06 May, 2022

Blockchain - an open, decentralised, secure, public ledger and the technology behind crypto currencies like bitcoin and ...Read more

EyePoint Pharma with Betta Pharma lay focus on eye diseases across the globe

Pharma |  News | 0 Comment | 05 May, 2022

EyePoint Pharmaceuticals has announced the execution of a license agreement with Betta Pharmaceuticals to develop and co...Read more

Jazz Pharma and Sumitomo Pharma to develop therapies for sleep disorders

Pharma |  News | 0 Comment | 05 May, 2022

Ireland-based Jazz Pharmaceuticals and Sumitomo Pharma Co. in Japan, have entered into an exclusive licensing agree...Read more

NiKang Therapeutics, Hansoh Pharma ink $200M worth deal for cancer treatment in Greater China

Pharma |  News | 0 Comment | 04 May, 2022

NiKang Therapeutics , a clinical stage biotech company focused on developing innovative small molecule oncology medicine...Read more

Servatus strengthens board with new appointment

Pharma |  News | 0 Comment | 04 May, 2022

Servatus Limited, an Australian biopharmaceutical company delivering leading novel autoimmune and microbiome therapies, ...Read more

Incyte and Maruho lay focus on inflammatory dermatologic diseases in Japan

Pharma |  News | 0 Comment | 03 May, 2022

Incyte and Maruho Co., Ltd. have announced that the companies have entered into a Strategic Alliance Agreement for the d...Read more

Visirna brings RNAi therapeutics for cardiovascular & metabolic diseases in Greater China

Pharma |  News | 0 Comment | 29 Apr, 2022

US-based Arrowhead Pharmaceuticals, Inc. has formed a joint venture, Visirna Therapeutics, with Vivo Capital t...Read more